Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Expands capacity and capabilities for induced pluripotent stem cell development and manufacturing.
May 20, 2026
By: Charlie Sternberg
Associate Editor
Fujifilm Cellular Dynamics Inc., a global developer and manufacturer of human-induced pluripotent stem cells (iPSCs), has opened a new headquarters and iPSC development and manufacturing facility in Madison, Wisconsin.
The new site is expected to quadruple the capacity for the company’s iPSC-based research products and services manufacturing footprint and expand capabilities across Fujifilm Cellular Dynamics’ research product portfolio. With an eye toward future demand for contract manufacturing of cell therapy products, the facility is designed to be scalable to accommodate a wide range of processes, from investigational drug manufacturing to commercial production.
The site will expand manufacturing of the company’s iPSC-derived iCell product lines, which are increasingly leveraged for new approach methods (NAMs) in drug discovery.
“The opening of this facility is an exciting milestone for Fujifilm Cellular Dynamics and represents a crucial next step for scaling the infrastructure needed to support the next generation of iPSC-based research and therapeutics in the U.S.,” said Tomoyuki Hasegawa, President and CEO of Fujifilm Cellular Dynamics. “By expanding our development and manufacturing capabilities, we can better support partners working to translate stem cell science into real clinical impact.”
As one part of a previously announced $200 million strategic investment by Fujifilm, the 175,000-square-foot building integrates robust capabilities, including cell culture manufacturing laboratories, process development laboratories, and a center of excellence for gene editing. The expanded capacity will advance development, manufacturing, and commercialization efforts across Fujifilm Cellular Dynamics’ portfolio.
The ribbon-cutting celebration was attended by Fujifilm’s leadership and state and local public officials, including Wisconsin Gov. Tony Evers, Deputy Secretary Sam Rikkers of Wisconsin Economic Development Corporation, Acting Consul General of Japan Naoya Kishi, and Madison Mayor Satya Rhodes-Conway.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !